Erickson Lab

LSU Health Sciences Center

NEUROSCIENCES

New Orleans · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Novel presynaptic agents to prevent glutamate-induced neural injury

Temporal lobe epilepsy is the most common form of focal (partial) or location related epilepsy. It affects about 60 percent of all people with epilepsy and can occur at any age. The kainic acid model of temporal lobe epilepsy has greatly contributed to the understanding of the molecular, cellular and pharmacological mechanisms underlying epileptogenesis. This model presents with neuropathological features that are seen in patients with temporal lobe epilepsy. There are many potential causes, and often the exact cause is unknown. Excessive presynaptic glutamate (Glu) release causes excessive stimulation of NMDA receptors that is implicated in many CNS disorders that result in acute and…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at LSU Health Sciences Center